Related references
Note: Only part of the references are listed.Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives
S. Rath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pretubulysin derived probes as novel tools for monitoring the microtubule network via activity-based protein profiling and fluorescence microscopy
Juergen Eirich et al.
MOLECULAR BIOSYSTEMS (2012)
Pretubulysin: From Hypothetical Biosynthetic Intermediate to Potential Lead in Tumor Therapy
Jennifer Herrmann et al.
PLOS ONE (2012)
Total Syntheses of Tubulysins
Taku Shibue et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Pretubulysin, a Potent and Chemically Accessible Tubulysin Precursor from Angiococcus disciformis
Angelika Ullrich et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Synthesis and Biological Evaluation of Pretubulysin and Derivatives
Angelika Ullrich et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2009)
First Total Synthesis of Tubulysin B
Orlando Pando et al.
ORGANIC LETTERS (2009)
Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction
Natalia V. Bogatcheva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
The total synthesis of tubulysin D
Hillary M. Peltier et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Drug Insight: vascular disrupting agents and angiogenesis - novel approaches for drug delivery
Matthew M. Cooney et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Biological evaluation of tubulysin A:: a potential anticancer and antiangiogenic natural product
Gurmeet Kaur et al.
BIOCHEMICAL JOURNAL (2006)
Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling
L Vincent et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
MAP kinases in lung endothelial permeability induced by microtubule disassembly
AA Birukova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death
C Kanthou et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Identification and analysis of the core biosynthetic machinery of tubulysin, a potent cytotoxin with potential anticancer activity
A Sandmann et al.
CHEMISTRY & BIOLOGY (2004)
Efficacy of combined antiangiogenic and vascular disrupting agents in treatment of solid tumors
DW Siemann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Semisynthesis and degradation of the tubulin inhibitors epothilone and tubulysin
G Höfle et al.
PURE AND APPLIED CHEMISTRY (2003)
Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models
SA Hill et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton
M Krendel et al.
NATURE CELL BIOLOGY (2002)
The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells
C Kanthou et al.
BLOOD (2002)
The biology of the combretastatins as tumour vascular targeting agents
GM Tozer et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2002)
Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation
AD Verin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)
Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors
R Murata et al.
RADIOTHERAPY AND ONCOLOGY (2001)
Characterization of p190RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules
FPG van Horck et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli - Production, isolation, physico-chemical and biological properties
F Sasse et al.
JOURNAL OF ANTIBIOTICS (2000)
Share Paper
